Key Points
- To review the global incidence, underlying pathophysiology, and predictive accuracy of risk assessment tools for perioperative cardiac events in patients undergoing noncardiac surgery.
- Narrative review evaluating clinical evidence on perioperative cardiac death, nonfatal myocardial infarction, and nonfatal cardiac arrest.
- Assessed predictive accuracy and clinical utility of generic risk indices (such as the Lee index), ACC/AHA algorithms, and noninvasive cardiac tests.
- Annually, between 500,000 and 900,000 patients worldwide experience perioperative cardiac death, nonfatal myocardial infarction, or nonfatal cardiac arrest during noncardiac surgery.
- The Lee index represents the most accurate generic perioperative risk tool, whereas substantial uncertainty persists regarding the predictive utility of noninvasive cardiac testing and the ACC/AHA algorithm.
- Evidence indicates that a substantial proportion of fatal perioperative myocardial infarctions possess distinct pathophysiological mechanisms compared to nonoperative events.
Structured PICO
PPopulationPatients undergoing noncardiac surgery
OOutcomePerioperative cardiac events (cardiac death, nonfatal myocardial infarction, or nonfatal cardiac arrest)
Accurate perioperative cardiac risk estimation, potentially best achieved with the Lee index, is crucial for informed decision-making in patients undergoing noncardiac surgery.
Limitations
- Limited evidence on the pathophysiology of fatal perioperative MIs
- Uncertainty regarding the predictive accuracy of noninvasive cardiac tests and the ACC/AHA algorithm